Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Dong Han, MS
Gilead Sciences, Inc.
Poster(s):
(506) Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(545) Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
